18 November 2020
By Leigh Dayton
They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.
Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]
By Leigh Dayton 9 Nov 2020
As well as steering the Melbourne-based biotech company through the challenges of COVID-19, CEO Alan Trounson has taken up the role of guest editor for the prestigious journal Cells.
It’s a perfect match. The journal’s upcoming special issue will […]
Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry
The Royal Swedish Academy of Sciences
7 October 2020
Using these tools, researchers can change the DNA of animals, plants and microorganisms with […]
View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter
Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.
By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]
22 September 2020
Finally, Anisha is back, well almost. She is currently in lockdown in Sydney. While there, she spoke with Cartherics Communication’s Advisor Leigh Dayton about her experience.
When and why did you go to India?
My dad passed away due to a cardiac arrest […]
Along with others Alan shares his experience in this short clip ………
We're celebrating 40 years of the GSK Award for Research Excellence (ARE) with support from our esteemed alumni.
Some of our past winners took time out in #lockdown to reflect on the impact of the ARE on their work & the importance of supporting Aussie research. #40YearsOfARE pic.twitter.com/cI67CeUpVo
— GSK Australia (@GSK_AU) September 2, 2020
For new recruit Walid Azar, it was about finding his calling.
As Walid Azar settles into his new dual role as Senior Research Fellow and Deputy Lab Manager at Cartherics, he feels content that he has finally found his calling. With previous experience in both cancer research and industry, he acknowledges having lived in the best […]
When considering whether to continue his translational research program at the Australian Regenerative Medicine Institute (ARMI), Frederico Calhabeu had a quick chat with Silvio Tiziani, Director, External Strategy and Planning at ARMI.
Silvio suggested a quiet word with several contacts in the […]
In celebration of National Science Week 2020, Solubility is supporting the#InspiringAustraliaInitiative by profiling five dynamic scientific careers.
Next up in our daily interview series is Dr Ian Nisbet.
What does your role entail?
Cartherics is harnessing the body’s immune system to target and kill cancer […]
By Leigh Dayton
“It’s good to get new money into Cartherics,” says the Cartherics’ Chief Scientific Officer Richard Boyd. He adds that the AU$120,000 in grant funding is particularly welcome as all Melbourne-based research and development (R&D) groups are managing the hurdles of […]
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
